Abstract:The epigenetic memory stored in the dynamic modifications, such as base modifications of cytosine (C) in DNA, including methylation/hydroxymethylation/demethylation, causes heritable phenotypes via regulating gene expression without alteration of DNA sequence. The process from cytosine modification to the epigenetic effect is orchestrated by complicated machinery consisting of writers, erasers, readers, and other factors. The two major forms of cytosine modification include methylcytosine (5-mC) and hydroxymethylcytosine (5-hmC). DNA methyltransferases (DNMTs) including DNMT1, DNMT3A, and DNMT3B function as writers for 5-mC. The ten-eleven translocation proteins (TET) including TET1, TET2, and TET3 in the mammalian genome are responsible for hydroxymethylation of 5-mC to generate 5-hmC, 5-formylcytosine (5-fC), and 5-carboxylcytosine (5-caC). The 5-mC and 5-hmC have become the two most extensively investigated epigenetic markers, and the dynamic balance of these two markers shape the landscape of the epigenome, functioning as a platform to regulate gene expression epigenetically. The landscape of the 5-hmC in epigenome is precisely and tightly regulated during the development. Aberrant alterations of the epigenetic regulation may cause severe consequences such as phenotype change as well as initiation of disease. Progressively, significant achievements have been made in characterization of writers, erasers, and readers of 5-mC and 5-hmC, as well as the contribution of aberrant alteration of 5-hmC/5-mC landscape to the pathogenesis of human diseases, such as cancers and neurological disorders. This article will highlight the research advances in the distinct contribution of TET proteins as suppressors or promoters to the pathogenesis of tumorigenesis and progression. Furthermore, this article also discusses the challenges and the directions for research in the future.

Ten-Eleven Translocation-2 (Tet2) Is Involved in Myogenic Differentiation of Skeletal Myoblast Cells in Vitro

Effects of Ten-Eleven Translocation-2 (tet2) on Myogenic Differentiation of Chicken Myoblasts.

TET Enzymes Regulate Skeletal Development Through Increasing Chromatin Accessibility of RUNX2 Target Genes

Interactive regulation of DNA demethylase gene<i> TET1</i> and m6A methyltransferase gene<i> METTL3</i> in myoblast differentiation

Muscle Regeneration Controlled by a Designated DNA Dioxygenase.

Disturbance of Calcium Homeostasis and Myogenesis Caused by TET2 Deletion in Muscle Stem Cells.

Knockdown of Tet2 Inhibits the Myogenic Differentiation of Chicken Myoblasts Induced by Ascorbic Acid

Phosphorylation of TET2 by AMPK is Indispensable in Myogenic Differentiation.

MSTN Mutant Promotes Myogenic Differentiation by Increasing Demethylase TET1 Expression via the SMAD2/SMAD3 Pathway

Histone Methyltransferase Setd2 is Critical for the Proliferation and Differentiation of Myoblasts

5Mc Oxidation by Tet2 Modulates Enhancer Activity and Timing of Transcriptome Reprogramming During Differentiation.

Ten-eleven Translocation 1 Mediated-Dna Hydroxymethylation is Required for Myelination and Remyelination in the Mouse Brain

Abstract MP245: Tet Proteins Regulate Second Heart Field Multipotent Progenitors Differentiating To Myocytes

5mC profiling characterized TET2 as an anti-adipogenic demethylase

Ten-eleven Translocation 2 Interacts with Forkhead Box O3 and Regulates Adult Neurogenesis

METTL3 Promotes Proliferation and Myogenic Differentiation Through M6a RNA Methylation/ythdf1/2 Signaling Axis in Myoblasts

Exploring high-resolution chromatin interaction changes and functional enhancers of myogenic marker genes during myogenic differentiation

A Novel Zinc Finger Protein Zfp637 Behaves As a Repressive Regulator in Myogenic Cellular Differentiation.

Specific Functions of TET1 and TET2 in Regulating Mesenchymal Cell Lineage Determination

Myogenic Regulatory Factors Transactivate the Tceal7 Gene and Modulate Muscle Differentiation.

Ten-eleven translocation proteins (TETs): tumor suppressors or tumor enhancers?